Find a Clinical Trial
Filter
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
18+
Recruiting now
Cancer Center
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
16+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology
HER2 Negative Breast Cancer
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Home and Bedside Visual Fields
Vision health
All genders
15-80
Recruiting now
Department of Ophthalmology
DEcIDED
Dry eyes
All genders
18+
Recruiting now
Department of Ophthalmology
NASA
Dry eyes
All genders
21+
Recruiting now
Department of Ophthalmology
IMPACT/SWAGGER
Non Exudative Age-Related Macular Degeneration Imaged with Swept Source Optical Coherence Tomography
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
Functional Imaging for Ocular Blood Flow with OCTA
Macular degeneration, Retinal disorders
All genders
18+
Recruiting now
Department of Ophthalmology
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center